Quest Diagnostics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jim Davis
Chief executive officer
US$12.7m
Total compensation
| CEO salary percentage | 9.3% |
| CEO tenure | 2yrs |
| CEO ownership | 0.07% |
| Management average tenure | 4yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$838m |
| Jun 30 2024 | n/a | n/a | US$836m |
| Mar 31 2024 | n/a | n/a | US$842m |
| Dec 31 2023 | US$13m | US$1m | US$850m |
| Sep 30 2023 | n/a | n/a | US$759m |
| Jun 30 2023 | n/a | n/a | US$790m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$12m | US$806k | US$942m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$4m | US$625k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$4m | US$577k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$749m |
| Mar 31 2020 | n/a | n/a | US$771m |
| Dec 31 2019 | US$3m | US$590k | US$835m |
| Sep 30 2019 | n/a | n/a | US$709m |
| Jun 30 2019 | n/a | n/a | US$707m |
| Mar 31 2019 | n/a | n/a | US$720m |
| Dec 31 2018 | US$3m | US$590k | US$733m |
| Sep 30 2018 | n/a | n/a | US$860m |
| Jun 30 2018 | n/a | n/a | US$808m |
| Mar 31 2018 | n/a | n/a | US$782m |
| Dec 31 2017 | US$3m | US$590k | US$769m |
Compensation vs Market: Jim's total compensation ($USD12.67M) is above average for companies of similar size in the BR market ($USD5.75M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Davis (61 yo)
2yrs
Tenure
US$12,673,834
Compensation
Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 2yrs | US$12.67m | 0.067% R$ 71.1m | |
| Executive VP & CFO | 2.3yrs | US$3.98m | 0.016% R$ 16.6m | |
| Senior VP & General Counsel | 25.3yrs | US$2.25m | 0.039% R$ 41.9m | |
| Executive Vice President of Regional Businesses | no data | US$3.16m | 0.058% R$ 61.5m | |
| Senior Vice President of Clinical Solutions | 2.3yrs | US$2.02m | 0.010% R$ 11.1m | |
| Senior VP | 5.6yrs | no data | 0.032% R$ 33.8m | |
| Senior VP | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | 2.1yrs | no data | no data | |
| Senior VP & Chief Communications Officer | 28yrs | no data | no data | |
| Senior VP & Chief Human Resources Officer | 6.8yrs | no data | no data | |
| Senior Vice President of Strategy | 8.8yrs | no data | no data |
4.0yrs
Average Tenure
61yo
Average Age
Experienced Management: Q1UE34's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 2yrs | US$12.67m | 0.067% R$ 71.1m | |
| Independent Director | 10.8yrs | US$315.44k | 0.022% R$ 23.8m | |
| Director | less than a year | no data | no data | |
| Lead Independent Director | 12.9yrs | US$345.94k | no data | |
| Independent Director | 19.9yrs | US$342.12k | no data | |
| Independent Director | 5.8yrs | US$312.33k | 0.0026% R$ 2.7m | |
| Independent Director | 10.3yrs | US$315.73k | 0.016% R$ 17.1m | |
| Independent Director | 4.7yrs | US$300.44k | no data | |
| Independent Director | 3.3yrs | US$300.44k | no data | |
| Independent Director | 1.5yrs | US$280.41k | no data |
5.2yrs
Average Tenure
65yo
Average Age
Experienced Board: Q1UE34's board of directors are considered experienced (5.2 years average tenure).